Collaborating Authors

This AI screening tool for diabetic retinopathy makes a decision, not a recommendation - MedCity News


Artificial intelligence is a healthcare and technology buzzword right now, but IDx Founder and President Michael Abràmoff is not a Johnny-come-lately to this phenomenon. His journey and that of the company's lead product began over two decades ago in the Netherlands.

AI Screening for Diabetic Retinopathy Moves to Retail Clinics


Retail health clinics have been part of the trend in making healthcare more convenient, and now another option is being offered -- testing for diabetic retinopathy. However, an ophthalmologist won't make the diagnosis at the clinic; instead, it will be made by an artificial intelligence (AI) system called IDx-DR. Testing will be offered through CarePortMD, the first retail health clinic to adopt this type of AI diagnostic technology, and offered at clinics inside Albertsons grocery stores. The second largest grocery chain in the United States, Albertsons added five CarePortMD clinics to stores in Delaware and Pennsylvania this past year. "Ours is a hybrid model of telehealth plus the convenience and access of a retail clinic, with the scalability and opportunity to coordinate with telemedicine." said Ashok Subramanian, MD, the CEO of CarePortMD.

Artificial intelligence begins diagnosing patients in Eastern Iowa


Federal cuts limit Iowa's access to health insurance enrollment services CORALVILLE -- The University of Iowa Hospitals and Clinics has become the first to employ new technology -- developed by a company rooted in the university's research engine -- that uses artificial intelligence to diagnose an eye disease. On June 12, the Diabetes and Endocrinology Center at UI Health Care-Iowa River Landing in Coralville began using technology developed by IDx, the Coralville-based medical diagnostics company. The device, which received approval from U.S. Food and Drug Administration in April, was developed to diagnose diabetic retinopathy, a diabetes complication that can cause blindness. Called IDx-DR, the device uses software and a retinal camera to take images of a patient's retina. From there, the AI analyzes the patient's images "the same way I do as a clinician" to determine if the patient has the condition, said Dr. Michael Abramoff, president and director of IDx and UI Health Care ophthalmologist.

AI is being used to spot the signs of a diabetes-induced eye disease

Daily Mail - Science & tech

One hospital is now allowing artificial intelligence to take the reigns and diagnose its patients. The UI Health Care-Iowa River Landing in Coralville, Iowa has become the first hospital to adopt a new AI-powered machine to spot the early warning signs of diabetic retinopathy. If left undiagnosed, the condition, which arises as a complication for patients who suffer with either type one or type two diabetes, can cause blindness. The machine is capable of scanning and analysing the retinas of at-risk patients and will provide its own diagnosis without any human assistance. Dubbed IDx-DR, the technology has an 87 per cent sensitivity for the disease.

Artificial Intelligence Getting Smarter! Innovations from the Vision Field


Posted on February 8th, 2022 by Michael F. Chiang, M.D., National Eye Institute One of many health risks premature infants face is retinopathy of prematurity (ROP), a leading cause of childhood blindness worldwide. ROP causes abnormal blood vessel growth in the light-sensing eye tissue called the retina. Left untreated, ROP can lead to lead to scarring, retinal detachment, and blindness. It's the disease that caused singer and songwriter Stevie Wonder to lose his vision. Now, effective treatments are available--if the disease is diagnosed early and accurately.